Search Results 821-830 of 18199 for Immunode

  1. SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction - Mayo Clinic

    Known active human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV) infection. Inactive hepatitis carrier status or low ...

  2. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    Are infected with human immunodeficiency virus (HIV);; QuantiFERON®-TB test or Purified Protein Derivative (PPD) skin test, or both, according to local ...

  3. Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients with Relapsed or Relapsed/Refractory Multiple Myeloma - Mayo Clinic

    Ongoing or active systemic infection, active hepatitis B or C virus infection, or known human immunodeficiency virus (HIV) positive; Any serious medical or ...

  4. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

  5. Study of MLN4924 Plus Azacitidine in Treatment-Naïve Patients With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older - Mayo Clinic

    Known human immunodeficiency virus (HIV) positive; Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection; Known ...

  6. Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy - Mayo Clinic

    Known history of a positive test for human immunodeficiency virus; Use of any active investigational drugs within 1 month or 5 half-lives of screening ...

  7. Pediatrics Clinical Trials - Medical Professionals

    These immune deficiency diseases are thought to be rare and include: Severe combined immunodeficiency (SCID), leukocyte adhesion deficiency (LAD), X-linked ...

  8. Study of bb2121 in Multiple Myeloma - Clinical Trials

    Known human immunodeficiency virus (HIV) positivity. Subjects with a history of class III or IV congestive heart failure or non-ischemic cardiomyopathy ...

  9. A Study Using Momelotinib in Transfusion-Dependent Adults with Primary Myelofibrosis, Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis - Mayo Clinic

    Prior splenectomy · Splenic irradiation within 3 months prior to the first dose of MMB · Prior treatment with MMB · Known positive status of human immunodeficiency ...

  10. P1101 in Treating Patients With Myelofibrosis - Mayo Clinic

    Immunocompromised patients or patients known to be human immunodeficiency virus (HIV) positive and currently receiving antiretroviral therapy; Uncontrolled ...